Patients with sickle cell disease and beta-thalassemia treated with exagamglogene autotemcel reported substantial and ...

IAUI provides income and capital preservation, making it appealing for income investors seeking diversification and reduced ...

XDIV earns a buy rating for its quality, income focus, and high yield, plus key risks and how best to use it. Click here to ...

The mean of analysts' price targets for Beam Therapeutics (BEAM) points to a 76.2% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement ...

The Federal Reserve’s September interest rate cut has triggered a shift in the corporate bond market, with spreads in both ...

The 3 mid-cap funds mentioned in this editorial were identified by evaluation of 5-year rolling CAGR and risk metrics such as ...

Get risk adjusted return analysis for Tata Nifty Next 50 Index Fund. Understand and compare data with category ratios. Get various ratios like beta, alpha, sharpe ratio, treynor ratio etc calculated ...

This study offers a valuable methodological advance by introducing a gene panel selection approach that captures combinatorial specificity to define cell identity. The findings address key limitations ...

Any investors hoping to find a Large Cap Value fund could think about starting with Vanguard Windsor Fund (VWNDX). VWNDX carries a Zacks Mutual Fund Rank of 2 (Buy), which is based on various ...

Any investors hoping to find a Small Cap Growth fund could think about starting with BlackRock Small Cap Growth Equity A (CSGEX). CSGEX holds a Zacks Mutual Fund Rank of 1 (Strong Buy), which is based ...

Muhurat Trading, the symbolic start of the new financial year in India, has begun, marking a period of festive optimism among ...